With more than 700 cases of measles in 23 states, the U.S. is seeing its highest number of infections in 25 years.
What can we do to stop this deadly disease from hurting our most vulnerable populations?
Former FDA Associate Commissioner and President of the Center for Medicine in the Public Interest, Peter Pitts dives into the measles outbreak and identifies the top three things responsible for this public health crisis.
Plus, he addresses common health concerns about the vaccine and explains if it's actually safe.
Bonus
Why Does Springtime Make Some People Depressed?
Selected Podcast
EP 942B - The Return of Measles
Featuring:
His book, Become Strategic or Die, is widely recognized as a cutting edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of the new book, Coincidence or Crisis, a discussion of global prescription medicine counterfeiting. He has served as an adjunct professor at Indiana University’s School of Public and Environmental Affairs and Butler University.
Peter Pitts, President & Co-Founder of the Center for Medicine in the Public Interest
Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest. Prior to founding CMPI, Pitts was a Senior Fellow for healthcare studies at the Pacific Research Institute. From 2002-2004 Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug task force.His book, Become Strategic or Die, is widely recognized as a cutting edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of the new book, Coincidence or Crisis, a discussion of global prescription medicine counterfeiting. He has served as an adjunct professor at Indiana University’s School of Public and Environmental Affairs and Butler University.
Tagged under